Stocktoria
C4 Therapeutics, Inc. CCCC
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-02
C4 Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,551,510 | $21.0M | 4.7% |
| TWO SIGMA INVESTMENTS, LP | 3,035,634 | $8.0M | 3.13% |
| CITADEL ADVISORS LLC | 2,588,615 | $6.8M | 2.67% |
| RENAISSANCE TECHNOLOGIES LLC | 2,461,815 | $6.5M | 2.54% |
| MILLENNIUM MANAGEMENT LLC | 1,393,342 | $3.7M | 1.44% |
| D. E. Shaw & Co., Inc. | 1,060,331 | $2.8M | 1.09% |
| Point72 Asset Management, L.P. | 169,096 | $444,722 | 0.17% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.